• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings

    2/29/24 12:24:24 PM ET
    $BBY
    $DAVA
    $ENVB
    $KA
    Consumer Electronics/Video Chains
    Consumer Discretionary
    EDP Services
    Technology
    Get the next $BBY alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday.

    The Dow traded down 0.16% to 38,884.96 while the NASDAQ rose 0.38% to 16,008.19. The S&P 500 also rose, gaining, 0.16% to 5,077.83.

    Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Real estate shares rose by 0.6% on Thursday.

    In trading on Thursday, health care shares fell by 0.5%.

     

    Top Headline

     

    Best Buy Co., Inc. (NYSE:BBY) posted better-than-expected fourth-quarter earnings.

    The company reported fourth-quarter adjusted earnings per share of $2.72, beating the street view of $2.51. Quarterly sales of $14.646 billion beat the analyst consensus of $14.533 billion.

    The firm approved a 2% increase in the regular quarterly dividend to $0.94 per share.

    Best Buy sees FY25 adjusted earnings per share of $5.75-$6.20 versus the $6.13 estimate. The company sees revenue of $41.3 billion-$42.6 billion versus $42.37 billion estimate.

     

    Equities Trading UP

     

    Societal CDMO, Inc. (NASDAQ:SCTL) shares shot up 132% to $1.0650. Privately held CoreRx Inc. will acquire Societal CDMO, a contract development and manufacturing organization.

    Shares of Enveric Biosciences, Inc. (NASDAQ:ENVB) got a boost, surging 155% to $2.12. Enveric Biosciences signed a non-binding term sheets to pursue the exclusive out-licensing of three classes of compounds.

    Vertex, Inc. (NASDAQ:VERX) shares were also up, gaining 32% to $33.46 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance.

     

    Equities Trading DOWN

     

    LivePerson, Inc. (NASDAQ:LPSN) shares dropped 40% to $1.4450 following fourth-quarter financial results.

    Shares of Endava plc (NYSE:DAVA) were down 39% to $38.99 following second-quarter earnings.

    Kineta, Inc. (NASDAQ:KA) was down, falling 44% to $1.29 as the company announced intention to explore strategic alternatives.

    Also Check This Out: Top 3 Energy Stocks That Could Sink Your Portfolio In Q1

     

    Commodities

     

    In commodity news, oil traded up 0.9% to $79.26 while gold traded up 0.5% at $2,053.80.

    Silver traded rose 0.8% to $22.82 on Thursday while copper rose 0.3% to $3.8510.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 rose 0.01%, London’s FTSE 100 rose 0.07% while Spain’s IBEX 35 Index fell 0.67% The German DAX gained 0.44% French CAC 40 fell 0.34% while Italy’s FTSE MIB Index declined 0.11%.

    German jobless rate held came in unchanged at 5.9% in February, while German retail sales fell by 0.4% month-over-month in January. Spanish annual consumer price inflation rate declined to a six-month low level of 2.8% in February.

    French economy expanded 0.1% on quarter in the fourth quarter. The annual inflation rate in France eased to 2.9% in February, while producer prices declined 1.3% month-over-month in January.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.11%, Hong Kong’s Hang Seng Index falling 0.15%, China’s Shanghai Composite Index gaining 1.94% and India’s S&P BSE Sensex gaining 0.27%.

    Indian fiscal deficit shrank to INR 11.03 trillion in April-January compared to INR 11.91 trillion in the year-ago period. Japanese housing starts fell by 7.5% year-over-year in January following a 4.0% decline in the previous month. Retail sales in Japan gained 2.3% year-over-year in January.

     

    Economics

     

    The annual PCE inflation rate eased slightly from 2.6% in December 2023 to 2.4% in January 2024. Excluding energy and food, the core PCE index saw a year-on-year surge of 2.8%, down from the 2.9% rate seen December and in line with the expected decrease to 2.8%.

    Personal spending rose by 0.2% from the previous month, while personal income rose by 1%.

    U.S. initial jobless claims rose by 13,000 to 215,000 in the week ending Feb. 24.

    The Chicago PMI declined to 44 in February from 46 in the previous month.

    Pending home sales in the U.S. fell by 4.9% from the prior month in January.

    U.S. natural-gas supplies fell 96 billion cubic feet of natural gas in the week ended Feb. 23, 2024.

    Now Read This: Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch

     

    Get the next $BBY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BBY
    $DAVA
    $ENVB
    $KA

    CompanyDatePrice TargetRatingAnalyst
    Vertex Inc.
    $VERX
    2/12/2026$16.00Buy → Hold
    Jefferies
    Vertex Inc.
    $VERX
    2/3/2026$20.00Overweight → Neutral
    Piper Sandler
    Best Buy Co. Inc.
    $BBY
    2/2/2026$76.00Overweight → Neutral
    Analyst
    Best Buy Co. Inc.
    $BBY
    11/26/2025$90.00 → $95.00Outperform
    Telsey Advisory Group
    Endava plc
    $DAVA
    11/12/2025$12.00 → $9.00Buy
    Needham
    Endava plc
    $DAVA
    11/11/2025Outperform → Mkt Perform
    William Blair
    Vertex Inc.
    $VERX
    11/4/2025$30.00 → $24.00Outperform
    BMO Capital Markets
    Vertex Inc.
    $VERX
    9/26/2025$30.00Overweight
    Stephens
    More analyst ratings

    $BBY
    $DAVA
    $ENVB
    $KA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vertex downgraded by Jefferies with a new price target

    Jefferies downgraded Vertex from Buy to Hold and set a new price target of $16.00

    2/12/26 7:24:07 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Vertex downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Vertex from Overweight to Neutral and set a new price target of $20.00

    2/3/26 6:54:33 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Best Buy downgraded by Analyst with a new price target

    Analyst downgraded Best Buy from Overweight to Neutral and set a new price target of $76.00

    2/2/26 6:48:04 AM ET
    $BBY
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $BBY
    $DAVA
    $ENVB
    $KA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data

    Proprietary assays demonstrate dual Gq and β-arrestin signaling at 5-HT₂A, pathways linked in peer-reviewed studies to antidepressant and anxiolytic effects A recent independent Nature study reports that distinct signaling pathways support mechanistic separation of therapeutic benefit from hallucinations Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced new mechanistic data demonstrating that its lead candidate, EB-003, activates both Gq- and β-arrestin–mediated signaling downstream of the 5-HT₂A receptor. Multiple independ

    2/19/26 8:00:00 AM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Endava Announces Second Quarter Fiscal Year 2026 Results

    Q2 FY2026 5.9% Year on Year Revenue Decline to £184.1 million 5.1% Revenue Decline at Constant Currency Diluted EPS £(0.13) compared to £0.11 in the prior year comparative period Adjusted Diluted EPS £0.16 compared to £0.30 in the prior year comparative period Endava plc (NYSE:DAVA) ("Endava" or the "Company"), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced results for the three months ended December 31, 2025 ("Q2 FY2026"). "Over the past several quarters we have been investing heavily in our pivot towards AI to establish Endava as an AI leader. These investments have encompassed

    2/19/26 7:15:00 AM ET
    $DAVA
    EDP Services
    Technology

    Endava Expands Cognition Partnership to Scale Governed Agentic Coding

    Endava (NYSE:DAVA), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, has today announced a significant expansion of its partnership with Cognition to help enterprises safely scale agentic software delivery and accelerate business outcomes. The move extends Endava's ability to deliver enterprise-grade, AI-native engineering for clients by broadening access to Cognition's Windsurf and Devin platforms, as a core enabler of the company's Dava.Flow™ delivery framework. The partnership is designed to improve the client experience of AI-assisted delivery; helping organisations move beyond isolated experime

    2/18/26 5:00:00 AM ET
    $DAVA
    EDP Services
    Technology

    $BBY
    $DAVA
    $ENVB
    $KA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Andersen Eric C. bought $516,400 worth of shares (40,000 units at $12.91), increasing direct ownership by 36% to 150,341 units (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/23/26 4:47:08 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Westphal Jeffrey bought $5,121,294 worth of shares (397,740 units at $12.88) (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/18/26 5:22:20 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    CEO Barry Corie S exercised 12,293 shares at a strike of $40.85, covered exercise/tax liability with 8,420 shares and bought $984,420 worth of shares (13,500 units at $72.92), increasing direct ownership by 5% to 378,780 units (SEC Form 4)

    4 - BEST BUY CO INC (0000764478) (Issuer)

    3/13/25 6:47:35 PM ET
    $BBY
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $BBY
    $DAVA
    $ENVB
    $KA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Andersen Eric C. bought $516,400 worth of shares (40,000 units at $12.91), increasing direct ownership by 36% to 150,341 units (SEC Form 4)

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/23/26 4:47:08 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Chief Accounting Officer Leib Ryan J

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/23/26 4:46:15 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by GENERAL COUNSEL Rowland Bryan T.R.

    4 - Vertex, Inc. (0001806837) (Issuer)

    2/23/26 4:45:37 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    $BBY
    $DAVA
    $ENVB
    $KA
    SEC Filings

    View All

    SEC Form 6-K filed by Endava plc

    6-K - Endava plc (0001656081) (Filer)

    2/19/26 7:19:12 AM ET
    $DAVA
    EDP Services
    Technology

    SEC Form 424B3 filed by Enveric Biosciences Inc.

    424B3 - Enveric Biosciences, Inc. (0000890821) (Filer)

    2/18/26 4:58:04 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Enveric Biosciences Inc.

    EFFECT - Enveric Biosciences, Inc. (0000890821) (Filer)

    2/18/26 12:15:38 AM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BBY
    $DAVA
    $ENVB
    $KA
    Leadership Updates

    Live Leadership Updates

    View All

    Nexus Global Payments Appoints Technical Operator

    PayNet and NETS joint venture awarded contract to be Nexus Technical Operator, with support from Endava and AWS Nexus Global Payments (NGP) appoints Payments Network Malaysia (PayNet) and Network for Electronic Transfers Singapore (NETS) joint venture as the Nexus Technical Operator (NTO). This follows a competitive procurement process involving global bidders and marks a major milestone in building an interoperable global payments infrastructure. The evaluation of bidders considered technical capability, operational resilience, cost efficiency, and alignment with Nexus' vision for global interoperability. PayNet and NETS joint venture emerged as the preferred partner due to the proven

    2/9/26 6:21:00 AM ET
    $DAVA
    EDP Services
    Technology

    ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

    ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today announced the appointment of David Johnson as Chairman of the Board. Mr. Johnson will work alongside CEO, Doron Besser, and the existing leadership team. David Johnson, newly appointed Chairman of ENvue, stated, "We believe ENvue is at the forefront of advanced feeding-tube placement technology, which has been validated in the market and extensively used in the clinic across 38 hospitals in the US. In my opinion, the Company's unique feeding tube placement system that utilizes advanced methods of navigation, integrated sensors and body mapping h

    12/15/25 9:00:00 AM ET
    $ENVB
    $FEED
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties

    Best Buy Appoints Dylan Jadeja to Board of Directors

    Best Buy Co., Inc. has appointed Dylan Jadeja, the chief executive officer of Riot Games, to its Board of Directors, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251201489132/en/Dylan Jadeja (Credit: Riot Games, Inc.) Jadeja has served as the chief executive officer of Riot Games since July 2023 and has been a member of its executive team for more than a decade. Riot Games, a prominent video game developer and publisher, was founded in 2006 with the goal to create and support the most player-focused games in the world. One of the company's most well-known titles, "League of Legends," is a prime example of

    12/1/25 4:15:00 PM ET
    $BBY
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $BBY
    $DAVA
    $ENVB
    $KA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Vertex Inc.

    SC 13G/A - Vertex, Inc. (0001806837) (Subject)

    11/14/24 4:31:49 PM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Enveric Biosciences Inc.

    SC 13G/A - Enveric Biosciences, Inc. (0000890821) (Subject)

    11/14/24 4:03:47 PM ET
    $ENVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BBY
    $DAVA
    $ENVB
    $KA
    Financials

    Live finance-specific insights

    View All

    Endava Announces Second Quarter Fiscal Year 2026 Results

    Q2 FY2026 5.9% Year on Year Revenue Decline to £184.1 million 5.1% Revenue Decline at Constant Currency Diluted EPS £(0.13) compared to £0.11 in the prior year comparative period Adjusted Diluted EPS £0.16 compared to £0.30 in the prior year comparative period Endava plc (NYSE:DAVA) ("Endava" or the "Company"), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced results for the three months ended December 31, 2025 ("Q2 FY2026"). "Over the past several quarters we have been investing heavily in our pivot towards AI to establish Endava as an AI leader. These investments have encompassed

    2/19/26 7:15:00 AM ET
    $DAVA
    EDP Services
    Technology

    Vertex Announces Fourth Quarter and Full Year 2025 Financial Results

    KING OF PRUSSIA, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results for its fourth quarter and full year ended December 31, 2025. "In 2025, Vertex delivered double-digit revenue growth and meaningful profitability improvements while making important investments in the future," said Christopher Young, President and Chief Executive Officer of Vertex. "We sustained our market position as the leading provider of indirect tax solutions to the enterprise and continued to onboard new customers at a healthy pace. In addition, our e-invoicing business enjoyed accelerat

    2/11/26 7:05:00 AM ET
    $VERX
    Computer Software: Prepackaged Software
    Technology

    Endava to Announce Q2 FY2026 Financial Results on February 19, 2026

    Endava plc (NYSE:DAVA), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced it will release results for the second quarter ended December 31, 2025, on Thursday February 19, 2026 before the opening of regular U.S. market hours. Following the release, John Cotterell, Endava's CEO and Mark Thurston, Endava's CFO, will discuss the results in a conference call beginning at 8:00 am ET. Conference call access information is: Participant Toll Free Dial-In Number: 1-844-481-2736 Participant International Dial-In Number: 1-412-317-0665 Conference ID: Endava Call Webcast: https://investors.e

    2/5/26 4:22:00 PM ET
    $DAVA
    EDP Services
    Technology